Results for mirabegron translation from English to Slovenian

mirabegron distributes to erythrocytes.
mirabegron se porazdeli v eritrocite.

effect of mirabegron on transporters
vpliv mirabegrona na transporterje

the active substance is mirabegron.
zdravilna učinkovina je mirabegron.

mirabegron is contraindicated in patients with
mirabegron je kontraindiciran pri bolnikih

mirabegron can increase blood pressure.
mirabegron lahko povzroči povišanje krvnega tlaka.

effect of mirabegron on cyp2d6 substrates
vpliv mirabegrona na substrate cyp2d6

mirabegron – used to treat overactive bladders
mirabegron – uporablja se za zdravljenje prekomerno aktivnega mehurja

betmiga contains the active substance mirabegron.
zdravilo betmiga vsebuje zdravilno učinkovino mirabegron.

the pharmacokinetics of mirabegron are not influenced by race.
rasa ne vpliva na farmakokinetiko mirabegrona.

betmiga 25 mg prolonged-release tablets mirabegron
betmiga 25 mg tablete s podaljšanim sproščanjem mirabegron

each tablet contains 25 mg or 50 mg of mirabegron.
ena tableta vsebuje 25 mg ali 50 mg mirabegrona.

mirabegron is transported and metabolised through multiple pathways.
transport in presnova mirabegrona potekata po več poteh.

betmiga is a medicine containing the active substance mirabegron.
betmiga je zdravilo, ki vsebuje zdravilno učinkovino mirabegron.

mirabegron is a potent and selective beta 3-adrenoceptor agonist.
mirabegron je močan in selektiven agonist adrenergičnih receptorjev beta 3.

caution should be exercised when administering mirabegron in these patients.
pri predpisovanju mirabegrona tem bolnikom je potrebna previdnost.

mirabegron inhibited p-gp-mediated drug transport at high concentrations.
v velikih koncentracijah je zavrl transport zdravil s p-gp.

therefore, mirabegron can be taken with or without food at the recommended dose.
zato se lahko mirabegron v priporočenem odmerku uporabi s hrano ali brez nje.

mirabegron has been administered to healthy volunteers at single doses up to 400 mg.
zdravim prostovoljcem so mirabegron dajali v enkratnih odmerkih do 400 mg.

interaction of mirabegron with a known cyp2d6 inhibitor is not expected and was not studied.
medsebojnega delovanja mirabegrona z znanim zaviralcem cyp2d6 ni pričakovati in ni bilo raziskano.

mirabegron is the major circulating component following a single dose of 14c-mirabegron.
mirabegron je po enem odmerku 14c-mirabegrona glavna snov v obtoku.